Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010
暂无分享,去创建一个
[1] R. Stoltzfus,et al. Elevated iron stores are associated with HIV disease severity and mortality among postpartum women in Zimbabwe , 2009, Public Health Nutrition.
[2] J M Taylor,et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. , 1990, The New England journal of medicine.
[3] H. Ullum,et al. High Plasma Levels of Intact and Cleaved Soluble Urokinase Receptor Reflect Immune Activation and Are Independent Predictors of Mortality in HIV-1-Infected Patients , 2005, Journal of acquired immune deficiency syndromes.
[4] C. Lewis,et al. Association of HIV Infection, Demographic and Cardiovascular Risk Factors With All-Cause Mortality in the Recent HAART Era , 2010, Journal of acquired immune deficiency syndromes.
[5] M. Woodward,et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.
[6] Samy Suissa,et al. The nested case-control study in cardiology. , 2003, American heart journal.
[7] P. Ridker,et al. Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women , 2002, Circulation.
[8] R. Detels,et al. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. , 1993, Journal of acquired immune deficiency syndromes.
[9] K. Marder,et al. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. , 2007, Archives of neurology.
[10] K. Covinsky,et al. Towards a combined prognostic index for survival in HIV infection: the role of ‘non‐HIV’ biomarkers , 2010, HIV medicine.
[11] J Schüpbach,et al. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. , 2000, The Journal of infectious diseases.
[12] H. Ullum,et al. Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. , 2000, Blood.
[13] D. DeMets,et al. Surrogate End Points in Clinical Trials: Are We Being Misled? , 1996, Annals of Internal Medicine.
[14] Nancy R Cook,et al. Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures , 2009, Annals of Internal Medicine.
[15] Holly Janes,et al. Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design , 2008, Journal of the National Cancer Institute.
[16] R. Detels,et al. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T‐cell measurements , 1998, AIDS.
[17] J. Feldman,et al. C-Reactive Protein Is an Independent Predictor of Mortality in Women With HIV-1 Infection , 2003, Journal of acquired immune deficiency syndromes.
[18] D. Fuchs,et al. Serum HIV–1 RNA Levels Compared to Soluble Markers of Immune Activation to Predict Disease Progression in HIV–1–Infected Individuals , 1998, International Archives of Allergy and Immunology.
[19] H. Cohen,et al. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. , 2003, The American journal of medicine.
[20] D. Brand,et al. Predictors of death within six months in patients with advanced AIDS , 2005, Palliative and Supportive Care.
[21] A. Phillips,et al. Interruption of Antiretroviral Therapy and Risk of Cardiovascular Disease in Persons with HIV-1 Infection: Exploratory Analyses from the SMART Trial , 2008, Antiviral therapy.
[22] S. Hazen,et al. Higher Plasma Myeloperoxidase Levels Are Not Associated with an Increased Risk for Cardiovascular Events in HIV-Infected Adults , 2008, HIV clinical trials.
[23] Mardge H. Cohen,et al. The Impact of Kidney Function at Highly Active Antiretroviral Therapy Initiation on Mortality in HIV-Infected Women , 2010, Journal of acquired immune deficiency syndromes.
[24] J. Fahey,et al. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] L. Myer,et al. Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa , 2007, BMC infectious diseases.
[26] D. DeMets,et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.
[27] A. Phillips,et al. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era , 2003, AIDS.
[28] H. Whittle,et al. Immunological predictors of survival in HIV type 2-infected rural villagers in Guinea-Bissau. , 2005, AIDS research and human retroviruses.
[29] F. Miedema,et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS , 2003, AIDS.
[30] P. Morlat,et al. Early evolution of plasma soluble TNF-alpha p75 receptor as a marker of progression in treated HIV-infected patients. , 2008, AIDS research and human retroviruses.
[31] H. Ullum,et al. Impaired production of cytokines is an independent predictor of mortality in HIV-1-infected patients , 2003, AIDS.
[32] O. Kirk,et al. Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[33] P. Ridker,et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.
[34] John W. Mellors,et al. Predictive Value of Immunologic and Virologic Markers After Long or Short Duration of HIV‐1 Infection , 2002, Journal of acquired immune deficiency syndromes.
[35] J. Danesh,et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.
[36] A. Evans,et al. C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease: The PRIME Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[37] D. Follmann,et al. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells , 2008, Proceedings of the National Academy of Sciences.
[38] H. Ullum,et al. p24 as a Predictor of Mortality in a Cohort of HIV-1-Infected Adults in Rural Africa , 2008, Journal of acquired immune deficiency syndromes.
[39] D. Vlahov,et al. Serum albumin as a prognostic indicator for HIV disease progression. , 2006, AIDS research and human retroviruses.
[40] L. Kuller,et al. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. , 2009, The Journal of infectious diseases.
[41] W. Fawzi,et al. C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor setting , 2007, AIDS.
[42] S. Hammer,et al. Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis , 2000 .
[43] Lewis H Kuller,et al. Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection , 2008, PLoS medicine.
[44] M. Lederman,et al. Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. , 2010, The Journal of infectious diseases.
[45] R. Collins,et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.
[46] B. Lau,et al. C-reactive protein is a marker for human immunodeficiency virus disease progression. , 2006, Archives of internal medicine.
[47] M. Lederman,et al. Serum Interleukin-6 (IL-6), IL-10, Tumor Necrosis Factor (TNF) Alpha, Soluble Type II TNF Receptor, and Transforming Growth Factor Beta Levels in Human Immunodeficiency Virus Type 1-Infected Individuals with Mycobacterium avium Complex Disease , 2001, Journal of Clinical Microbiology.
[48] D. Katzenstein,et al. The evaluation of the HIV/AIDS Drug Access Initiatives in Côte D'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa , 2003, AIDS.
[49] D. Jacobs,et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. , 2010, The Journal of infectious diseases.
[50] A. Phillips,et al. The role of HIV in serious diseases other than AIDS , 2008, AIDS.
[51] N. Pantazis,et al. Elevated serum levels of soluble immune activation markers are associated with increased risk for death in HAART-naive HIV-1-infected patients. , 2003, AIDS patient care and STDs.
[52] R. D'Agostino,et al. Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. , 2008, Circulation.
[53] H. Cohen,et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.
[54] R. Salamon,et al. Factors Associated with Mortality in Human Immunodeficiency Virus Type 1–Infected Adults Initiating Protease Inhibitor–Containing Therapy: Role of Education Level and of Early Transaminase Level Elevation (APROCO–ANRS EP11 Study) , 2002 .
[55] L. Kuller,et al. Lipoprotein particle subclasses, cardiovascular disease and HIV infection. , 2009, Atherosclerosis.
[56] R Peto,et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.
[57] G. Sirugo,et al. Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction. , 2009, The American journal of clinical nutrition.
[58] C. Sabin,et al. Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study , 2002, The Lancet.
[59] D. Freedman,et al. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. , 2002, The American journal of cardiology.
[60] A. Zolopa,et al. Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort , 2010, Journal of acquired immune deficiency syndromes.
[61] L. Kuller,et al. Serum Amyloid P and Cardiovascular Disease in Older Men and Women: Results from the Cardiovascular Health Study , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[62] Karla Kerlikowske,et al. Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model , 2008, Annals of Internal Medicine.
[63] Mardge H. Cohen,et al. Serum Albumin Is a Powerful Predictor of Survival Among HIV‐1‐Infected Women , 2003, Journal of acquired immune deficiency syndromes.
[64] L. Szczech,et al. Development of Proteinuria or Elevated Serum Creatinine and Mortality in HIV-Infected Women , 2003, Journal of acquired immune deficiency syndromes.
[65] J. Danesh,et al. Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis , 2001, Circulation.
[66] M. Clerici,et al. Tumor Necrosis Factor β and Soluble APO-1/Fas Independently Predict Progression to AIDS in HIV-Seropositive Patients , 1998 .
[67] K. Marder,et al. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia , 2004, Neurology.
[68] G. Beall,et al. Infection with HIV is associated with elevated IL-6 levels and production. , 1990, Journal of immunology.
[69] H Tunstall-Pedoe,et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. , 2005, JAMA.
[70] Roger Detels,et al. Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.
[71] S. Reis,et al. Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women: The National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.